Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2010
02/04/2010US20100028857 Method for Detecting and for Removing Endotoxin
02/04/2010US20100028719 Surface-Immobilized Antimicrobial Peptoids
02/04/2010US20100028559 Method for functionalizing materials and devices comprising such materials
02/04/2010US20100028474 Sesame seed derived pigments
02/04/2010US20100028386 Recombinant p. falciparum merozoite protein-142 vaccine
02/04/2010US20100028378 Toxin-antitoxin system and applications thereof
02/04/2010US20100028377 Recombinant RSV Virus Expression Systems And Vaccines
02/04/2010US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
02/04/2010US20100028372 Stabilization of aqueous compositions of proteins with displacement buffers
02/04/2010US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
02/04/2010US20100028370 Megalin-based delivery of therapeutic compounds to the brain and other tissues
02/04/2010US20100028356 Method of diagnosing a neurodegenerative disease
02/04/2010US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
02/04/2010US20100028343 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein
02/04/2010US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/04/2010DE19681438B4 Verwendung von Polypeptidanaloga mit erhöhter Elektrotransportierbarkeit und Parathormon (PTH) - Analog Use of polypeptide analogs with increased Elektrotransportierbarkeit and parathyroid hormone (PTH) - Analog
02/04/2010CA2732574A1 Multi-specific binding proteins targeting b cell disorders
02/04/2010CA2732445A1 Method for the in vitro diagnosis of stroke
02/04/2010CA2732439A1 Halogen-stabilized insulin
02/04/2010CA2731038A1 Plants having modified growth characteristics and a method for making the same
02/04/2010CA2730714A1 Factor viii polymer conjugates
02/03/2010EP2149606A1 Nucleic acid molecules and methods for identifying modulators of GPR84 activity
02/03/2010EP2149604A1 Collections of repeat proteins comprising repeat modules
02/03/2010EP2149584A1 Method for enhancing immune response with peptide
02/03/2010EP2149583A1 Modified VP1-capsid protein of parvovirus B19
02/03/2010EP2148889A1 Modified plant defensin
02/03/2010EP2148697A1 Lyophilised antigen composition
02/03/2010EP2148692A2 Melanocortin receptor ligands modified with hydantoin
02/03/2010EP1893032B1 Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease
02/03/2010EP1773876B1 Hpv vaccine comprising peptides from host cell proteins
02/03/2010EP1687419B1 Hybrid enzymes
02/03/2010EP1646650B9 Recombinant igf expression systems
02/03/2010CN101638438A Human epididymis protease profilin immunological contraception polypeptide
02/03/2010CN101638437A Growth hormone fusion protein
02/03/2010CN101638436A Extracted corn protein and production method thereof
02/03/2010CN101638435A Blue-green algal virus protein N mutant, modified derivative and application thereof
02/03/2010CN101638434A Xenorhabdus nematophila apastia protein and gene sequence thereof and application of same
02/03/2010CN101638433A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
02/03/2010CN100587068C Use of multiple recombination sites with unique specificity in recombinational cloning
02/03/2010CN100586926C Method for producing acylated peptides
02/03/2010CN100586481C Hapten-carrier conjugates for treating and preventing nicotine addiction
02/02/2010US7657385 Structure-based hepatitis C virus drug design
02/02/2010US7657378 Computer based method for identifying peptides useful as drug targets
02/02/2010US7655849 Plants and seeds of hybrid corn variety CH515277
02/02/2010US7655843 Maize variety PHRAT
02/02/2010US7655838 Insect inhibitory Bacillus thuringiensis proteins, fusions, and methods of use therefor
02/02/2010US7655834 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector
02/02/2010US7655782 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies
02/02/2010US7655781 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
02/02/2010US7655774 Ancestral and COT viral sequences, proteins and immunogenic compositions
02/02/2010US7655773 Arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases
02/02/2010US7655772 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders
02/02/2010US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
02/02/2010US7655766 Partially dePEGylated lysine/N-terminal positional PEG isomers of a recombinant G-CSF polypeptide, such recombinant G-CSF polypeptide containing the substitutions K16R, K34R, K40R, T105K and S159K relative to wild-type human G-CSF; increasing the level of neutrophils in a patient
02/02/2010US7655761 IL-17-like cytokine binding compounds and antibodies
02/02/2010US7655760 Antibodies to the polypeptide hormone phosphatonin
02/02/2010US7655758 Tumor rejection antigen precursor fusion protein capable of binding to IL-1; histidine buffer; polyethylene glycol organic co-solvent or bulking agent; glycine, arginine, sucrose lyoprotectants; prefilled dual-chambered receptacle, single use injectable dose
02/02/2010US7655757 Cytotoxic ribonuclease variants
02/02/2010US7655756 Peptide fragment comprising the Ligand Binding Domain (LBD) of ERR gamma in complex with Bisphenol A; used to design or select compounds which have an effect on ERR gamma activity; drug screening
02/02/2010US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it
02/02/2010US7655754 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a SecA protein with increased levels of protein secretion, and methods for producing proteins
02/02/2010US7655753 Conjugate
02/02/2010US7655752 TNF-α converting enzyme inhibitory agents and method of using same
02/02/2010US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent
02/02/2010US7655631 Pharmaceutical preparations and methods for inhibiting tumors
02/02/2010US7655629 Peptides and their use for the treatment of HIV infections
02/02/2010US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis
02/02/2010US7655627 Mutein of human FGF-21 containing an engineered disulfide where cysteine replaces leucine 118 and alanine 134, alanine for serine 167; reduced deamidation and capacity of O-glycosylation compared to wild-type human FGF-21; antidiabetic agents, type 2 diabetes; obesity; metabolic syndrome
02/02/2010US7655626 Antiangiogenic peptides
02/02/2010US7655622 Administering melanocyte stimulating hormone to peripheral tissue
02/02/2010US7655619 Insulin-associated peptides with effects on cerebral health
02/02/2010US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents
02/02/2010US7655615 Surface and/or the interior of bone material is charged with bone morphogenic proteins and is sheathed with resorbable material
02/02/2010US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer
02/02/2010US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase
02/02/2010US7655462 Anti-tumor activity of Ea-4-peptide of pro-IGF-I
02/02/2010US7655460 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins with mutations associated with epilepsy
02/02/2010US7655458 Endostatin for use in the treatment of cancer and tumor metastasis
02/02/2010US7655447 ZSIG33-like polynucleotides
02/02/2010US7655441 Nucleic acid sequences having gene transcription regulatory qualities
02/02/2010US7655440 Nucleotide sequences coding ligand gated ion channel and/or glutarnate gated chloride channel for use in screening insecticides
02/02/2010US7655438 Antisense polynucleotide; cancer; polypeptide comprising the protein encoded by the polynucleotide sequence
02/02/2010US7655437 Enables an expression level equal to or higher than 52% of the recombinant hG-CSF to the total proteins after expression; useful in hematology and oncology
02/02/2010US7655427 Immunogenic proteins of Leptospira
02/02/2010US7655426 Ephrin-B receptor protein involved in carcinoma
02/02/2010US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES
02/02/2010US7655422 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners
02/02/2010US7655418 Identifying modulators of preferential lyase for use as tool in controlling crop pests; biological pest control; disease resistant plants
02/02/2010US7655413 Methods and compositions for enhanced protein expression and purification
02/02/2010US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B
02/02/2010US7655411 Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
02/02/2010US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues
02/02/2010US7655406 Expression vector comprising nucleotide sequences coding non-structural proteins of hepatitis virus for use in identifying modulators which prevent viral infections
02/02/2010US7655396 Methods for detecting receptor modulator activity
02/02/2010US7655395 Genes, cloned and amplified in bacterial cells; gene expression in insect cells shows that recombinant protein folds into a functional calcium release channel; drug screening of insecticides and pesticides; overcoming toxic effects of expressing recombinant proteins in host cells
02/02/2010US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
02/02/2010US7655246 Chlamydia protein, gene sequence and uses thereof
02/02/2010US7655245 Meningococcal serotype polypepties for use in diagnosis, prevention and treatment of microorganismal infection
02/02/2010US7655242 Defensin-inducing agents
02/02/2010US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders